End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
81.8
CNY
|
+3.02%
|
|
+2.89%
|
+31.45%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,160
|
7,131
|
8,830
|
10,537
|
13,852
|
-
|
-
|
Enterprise Value (EV)
1 |
6,160
|
7,131
|
8,830
|
10,537
|
13,852
|
13,852
|
13,852
|
P/E ratio
|
32.2
x
|
53.7
x
|
22.7
x
|
15.2
x
|
14.5
x
|
11.8
x
|
9.51
x
|
Yield
|
-
|
-
|
1.92%
|
2.41%
|
1.72%
|
2.11%
|
2.43%
|
Capitalization / Revenue
|
-
|
6.54
x
|
5
x
|
4.39
x
|
4.17
x
|
3.23
x
|
2.62
x
|
EV / Revenue
|
-
|
6.54
x
|
5
x
|
4.39
x
|
4.17
x
|
3.23
x
|
2.62
x
|
EV / EBITDA
|
-
|
29.7
x
|
16.1
x
|
10.8
x
|
10.9
x
|
8.93
x
|
7.3
x
|
EV / FCF
|
-
|
-
|
337
x
|
72.6
x
|
25.5
x
|
15.8
x
|
11.8
x
|
FCF Yield
|
-
|
-
|
0.3%
|
1.38%
|
3.93%
|
6.35%
|
8.45%
|
Price to Book
|
-
|
4.49
x
|
4.54
x
|
4.15
x
|
4.09
x
|
3.23
x
|
2.47
x
|
Nbr of stocks (in thousands)
|
169,320
|
169,320
|
169,320
|
169,320
|
169,339
|
-
|
-
|
Reference price
2 |
36.38
|
42.11
|
52.15
|
62.23
|
81.80
|
81.80
|
81.80
|
Announcement Date
|
4/16/21
|
4/22/22
|
4/19/23
|
4/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,090
|
1,765
|
2,400
|
3,321
|
4,284
|
5,289
|
EBITDA
1 |
-
|
240.2
|
549.9
|
974.1
|
1,272
|
1,551
|
1,896
|
EBIT
1 |
-
|
156.9
|
463.7
|
871
|
1,131
|
1,400
|
1,722
|
Operating Margin
|
-
|
14.39%
|
26.27%
|
36.29%
|
34.06%
|
32.68%
|
32.57%
|
Earnings before Tax (EBT)
1 |
-
|
154.8
|
461.4
|
866.3
|
1,129
|
1,397
|
1,719
|
Net income
1 |
163.5
|
132.9
|
388.1
|
733.6
|
957.3
|
1,176
|
1,456
|
Net margin
|
-
|
12.18%
|
21.99%
|
30.57%
|
28.82%
|
27.45%
|
27.54%
|
EPS
2 |
1.130
|
0.7847
|
2.292
|
4.098
|
5.652
|
6.945
|
8.600
|
Free Cash Flow
1 |
-
|
-
|
26.23
|
145.1
|
544
|
879
|
1,170
|
FCF margin
|
-
|
-
|
1.49%
|
6.05%
|
16.38%
|
20.52%
|
22.12%
|
FCF Conversion (EBITDA)
|
-
|
-
|
4.77%
|
14.9%
|
42.75%
|
56.66%
|
61.69%
|
FCF Conversion (Net income)
|
-
|
-
|
6.76%
|
19.79%
|
56.83%
|
74.74%
|
80.34%
|
Dividend per Share
2 |
-
|
-
|
1.000
|
1.500
|
1.408
|
1.728
|
1.985
|
Announcement Date
|
4/16/21
|
4/22/22
|
4/19/23
|
4/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
2023 S1
|
---|
Net sales
1 |
-
|
602.5
|
1,190
|
EBITDA
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
Net income
1 |
160.2
|
190.3
|
350.5
|
Net margin
|
-
|
31.59%
|
29.45%
|
EPS
|
0.9463
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
4/25/23
|
8/17/23
|
8/17/23
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
26.2
|
145
|
544
|
879
|
1,170
|
ROE (net income / shareholders' equity)
|
-
|
8.68%
|
22%
|
32.2%
|
29.1%
|
28.6%
|
26.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
19.5%
|
21%
|
20.7%
|
Assets
1 |
-
|
-
|
-
|
-
|
4,915
|
5,612
|
7,040
|
Book Value Per Share
2 |
-
|
9.390
|
11.50
|
15.00
|
20.00
|
25.30
|
33.10
|
Cash Flow per Share
2 |
-
|
0.9000
|
1.700
|
4.720
|
3.500
|
7.230
|
6.490
|
Capex
1 |
-
|
209
|
261
|
654
|
383
|
400
|
352
|
Capex / Sales
|
-
|
19.21%
|
14.79%
|
27.24%
|
11.54%
|
9.35%
|
6.66%
|
Announcement Date
|
4/16/21
|
4/22/22
|
4/19/23
|
4/16/24
|
-
|
-
|
-
|
Last Close Price
81.8
CNY Average target price
103.8
CNY Spread / Average Target +26.87% Consensus |
1st Jan change
|
Capi.
|
---|
| +31.45% | 1.91B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|